CA2510876A1 - Method of manufacturing integrated biosensors - Google Patents
Method of manufacturing integrated biosensors Download PDFInfo
- Publication number
- CA2510876A1 CA2510876A1 CA002510876A CA2510876A CA2510876A1 CA 2510876 A1 CA2510876 A1 CA 2510876A1 CA 002510876 A CA002510876 A CA 002510876A CA 2510876 A CA2510876 A CA 2510876A CA 2510876 A1 CA2510876 A1 CA 2510876A1
- Authority
- CA
- Canada
- Prior art keywords
- tissue penetration
- recess
- penetration members
- assembly apparatus
- strips
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150358—Strips for collecting blood, e.g. absorbent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/14—Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
- A61B5/1405—Devices for taking blood samples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/150022—Source of blood for capillary blood or interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150274—Manufacture or production processes or steps for blood sampling devices
- A61B5/150282—Manufacture or production processes or steps for blood sampling devices for piercing elements, e.g. blade, lancet, canula, needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150442—Blade-like piercing elements, e.g. blades, cutters, knives, for cutting the skin
Abstract
The determination of analyte concentration in physiological samples is of ever increasing importance to today's society. Such assays find use in a variety of applications, including clinical laboratory testing, home testing, etc., where the results of such testing play a prominent role in the diagnosis and management of a variety of disease conditions. In the present application, a method is described which may be used for the manufacture of medical devices which include an integrated lancet and sensor.
Description
METHOD OF MANUFACTURING INTEGRATED BIOSENSORS
BACKGROUND OF THE INVENTION
The present invention relates, in general, to medical devices containing an integrated lancet and sensor and, more particularly, to a process for manufacturing the medical devices.
The determination of analyte concentration in physiological samples is of ever increasing importance to today's society. Such assays find use in a variety of applications, including clinical laboratory testing, home testing, etc., where the results of such testing play a prominent role in the diagnosis and management of a variety of disease conditions. Analytes of interest include glucose for diabetes management, cholesterol for monitoring cardiovascular conditions, drugs for monitoring levels of therapeutic agents, and identifying illegal levels of drugs, and the like, In response to this growing importance of analyte concentration determination, a variety of analyte concentration determination protocols and devices for both clinical and home testing have been developed.
In determining the concentration of an analyte in a physiological sample, a physiological sample must first be obtained. Obtaining and testing the sample often involves cumbersome and complicated procedures. Unfortunately, successful manipulation and handling of test elements, such as test strips, lancing members, meters and the like is to a great extent dependent on the visual acuity and manual dexterity of the user, which in the case of people with diabetes is subject to deterioration over the course of the disease state. In extreme cases people that have significant loss of sight and sensation, testing procedures can become significantly di~cult and require additional assistance from ancillary devices or personnel.
A typical procedure for making a glucose measurement with the use of a test strip involves the following actions or steps (but not necessarily in the order given): (1) removing supplies from a carrying case, (2) removing a lancing device loading cap or door, (3) removing and disposing of a used lancet from the lancing 4 .
device, (4) inserting the lancet in the lancing device, (5) twisting off a protective cap from the lancet, (6) replacing the lancing device cap, (7) cocking the lancing device, (8) opening a test strip viaUcontainer, (9) removing a strip from the container and inserting or interfacing it with a meter, (10) holding a lancing device to the skin, (11) firing the lancing device, (12) removing the lancing device from the skin, (13) extracting a sample, (14) applying sample to the test strip and obtaining results of the measurement; (15) disposing of the test strip, (16) cleaning the test site, and (17) returning supplies to the carrying case. Of course, certain glucose measurement systems and protocols may involve fewer or more steps.
One manner of reducing the number of actions is by the use of integrated medical devices that combine multiple functions in order to minimize the handling of sensor and/or lancing components that may lead to contamination of the components and/or injury to the user. An example of such an integrated medical device that includes a test strip and lancet is described in International Application No. PCT/GBO1/05634 (published as WO 02/49507 on June 27, 2002) and U.S. Patent Application No. 10/143,399.
Technological advancements have been made in test strip fabrication in which both sensor and lancing functions and the structures to provide such functions are provided on a single fully integrated medical device, as described in the aforementioned U.S. Patent Application No. 10/143,399. Integrated medical devices are typically in the form of strips. Web-based methods can be used to make such fully integrated medical devices which are singulated after fabrication prior to being collectively packaged in a cartridge, magazine, cassette or the like. Examples of web-based methods for making such medical devices are disclosed in U.S. Patent Application No. 10/142,409 and European Patent Application EP 1360932 A1.
These web-based methods, however, require expensive equipment that requires substantial manufacturing floor space. In web-based methods, the alignment of the sensor and lance can also change during the manufacturing process. The sensor and lance must, however, be precisely aligned to ensure proper function of the integrated medical device.
BACKGROUND OF THE INVENTION
The present invention relates, in general, to medical devices containing an integrated lancet and sensor and, more particularly, to a process for manufacturing the medical devices.
The determination of analyte concentration in physiological samples is of ever increasing importance to today's society. Such assays find use in a variety of applications, including clinical laboratory testing, home testing, etc., where the results of such testing play a prominent role in the diagnosis and management of a variety of disease conditions. Analytes of interest include glucose for diabetes management, cholesterol for monitoring cardiovascular conditions, drugs for monitoring levels of therapeutic agents, and identifying illegal levels of drugs, and the like, In response to this growing importance of analyte concentration determination, a variety of analyte concentration determination protocols and devices for both clinical and home testing have been developed.
In determining the concentration of an analyte in a physiological sample, a physiological sample must first be obtained. Obtaining and testing the sample often involves cumbersome and complicated procedures. Unfortunately, successful manipulation and handling of test elements, such as test strips, lancing members, meters and the like is to a great extent dependent on the visual acuity and manual dexterity of the user, which in the case of people with diabetes is subject to deterioration over the course of the disease state. In extreme cases people that have significant loss of sight and sensation, testing procedures can become significantly di~cult and require additional assistance from ancillary devices or personnel.
A typical procedure for making a glucose measurement with the use of a test strip involves the following actions or steps (but not necessarily in the order given): (1) removing supplies from a carrying case, (2) removing a lancing device loading cap or door, (3) removing and disposing of a used lancet from the lancing 4 .
device, (4) inserting the lancet in the lancing device, (5) twisting off a protective cap from the lancet, (6) replacing the lancing device cap, (7) cocking the lancing device, (8) opening a test strip viaUcontainer, (9) removing a strip from the container and inserting or interfacing it with a meter, (10) holding a lancing device to the skin, (11) firing the lancing device, (12) removing the lancing device from the skin, (13) extracting a sample, (14) applying sample to the test strip and obtaining results of the measurement; (15) disposing of the test strip, (16) cleaning the test site, and (17) returning supplies to the carrying case. Of course, certain glucose measurement systems and protocols may involve fewer or more steps.
One manner of reducing the number of actions is by the use of integrated medical devices that combine multiple functions in order to minimize the handling of sensor and/or lancing components that may lead to contamination of the components and/or injury to the user. An example of such an integrated medical device that includes a test strip and lancet is described in International Application No. PCT/GBO1/05634 (published as WO 02/49507 on June 27, 2002) and U.S. Patent Application No. 10/143,399.
Technological advancements have been made in test strip fabrication in which both sensor and lancing functions and the structures to provide such functions are provided on a single fully integrated medical device, as described in the aforementioned U.S. Patent Application No. 10/143,399. Integrated medical devices are typically in the form of strips. Web-based methods can be used to make such fully integrated medical devices which are singulated after fabrication prior to being collectively packaged in a cartridge, magazine, cassette or the like. Examples of web-based methods for making such medical devices are disclosed in U.S. Patent Application No. 10/142,409 and European Patent Application EP 1360932 A1.
These web-based methods, however, require expensive equipment that requires substantial manufacturing floor space. In web-based methods, the alignment of the sensor and lance can also change during the manufacturing process. The sensor and lance must, however, be precisely aligned to ensure proper function of the integrated medical device.
a a Still needed in the field, therefore, is an inexpensive and simple method of fabricating an integrated medical device containing a lancet and a test strip.
This method should also produce integrated medical devices in which the sensor and lance are precisely aligned.
SUMMARY OF THE INVENTION
In one embodiment of the present invention a method of assembling integrated medical devices includes the steps of providing a medical device assembly apparatus including a body having a proximal end, and a distal end, a detachable clamping bar, and a pusher plate. In this embodiment of the present invention, the proximal end of the assembly apparatus includes a plurality of recesses for receiving and removably retaining a plurality of test strips at least partially therein.
In this embodiment of the invention, the method includes loading a test strip containing a top layer of heat-seal adhesive into each recess, placing a plurality of dermal tissue penetration members on top of the test strips, securing the plurality of dermal tissue penetration members with the clamping bar to minimize movement, urging the test strips into alignment with the dermal tissue penetration members using the pusher plate, heating the dermal tissue penetration members to a predetermined temperature to adhere the strips to the dermal tissue penetration members and removing the medical devices from the assembly apparatus for further processing. In the method of one embodiment of the present invention, heat is applied evenly across the dermal tissue penetration members to ensure complete adhesion between the strips and the dermal tissue penetration members. In one embodiment of the method according to the present invention, the dermal tissue penetration members are connected by a bandolier. In one embodiment of the method according to the present invention, the predetermined temperature is between 95°C and 150°C.
BRIEF DESCRIPTION OF THE DRAWINGS
A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings (wherein like numerals represent like elements), of which:
Figure 1 is an exploded perspective view of an integrated medical device assembly apparatus according to an embodiment of the present invention;
Figures 2A and 2B are perspective and side views, respectively, of a medical device that can be used with exemplary embodiments of the assembly apparatus according to the present invention;
Figures 3A and 3B are cross-sectional side views of a portion of the medical device assembly apparatus of Figure 1B along A-A' in the direction of the arrows, representing exemplary embodiments of assembly apparatus recesses.
Figures 4A and 4B are perspective and exploded perspective views, respectively, of an integrated medical device assembly apparatus according to another exemplary embodiment of the present invention;
Figure 5 is a flow chart illustrating a sequence of steps in a process for manufacturing an integrated medical device using the assembly apparatuses according to exemplary embodiments of the present invention;
Figures 6A-6H are schematic, perspective views depicting stages of a process for manufacturing medical devices according to present invention; and Figures 7A-7I are schematic perspective views depicting stages of a process for manufacturing medical devices according to the present invention.
DETAILED DESCRIPTION OF TAE INVENTION
Figure 1 is an exploded perspective view of a medical device assembly apparatus 100 according to an exemplary embodiment of the present invention.
This method should also produce integrated medical devices in which the sensor and lance are precisely aligned.
SUMMARY OF THE INVENTION
In one embodiment of the present invention a method of assembling integrated medical devices includes the steps of providing a medical device assembly apparatus including a body having a proximal end, and a distal end, a detachable clamping bar, and a pusher plate. In this embodiment of the present invention, the proximal end of the assembly apparatus includes a plurality of recesses for receiving and removably retaining a plurality of test strips at least partially therein.
In this embodiment of the invention, the method includes loading a test strip containing a top layer of heat-seal adhesive into each recess, placing a plurality of dermal tissue penetration members on top of the test strips, securing the plurality of dermal tissue penetration members with the clamping bar to minimize movement, urging the test strips into alignment with the dermal tissue penetration members using the pusher plate, heating the dermal tissue penetration members to a predetermined temperature to adhere the strips to the dermal tissue penetration members and removing the medical devices from the assembly apparatus for further processing. In the method of one embodiment of the present invention, heat is applied evenly across the dermal tissue penetration members to ensure complete adhesion between the strips and the dermal tissue penetration members. In one embodiment of the method according to the present invention, the dermal tissue penetration members are connected by a bandolier. In one embodiment of the method according to the present invention, the predetermined temperature is between 95°C and 150°C.
BRIEF DESCRIPTION OF THE DRAWINGS
A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings (wherein like numerals represent like elements), of which:
Figure 1 is an exploded perspective view of an integrated medical device assembly apparatus according to an embodiment of the present invention;
Figures 2A and 2B are perspective and side views, respectively, of a medical device that can be used with exemplary embodiments of the assembly apparatus according to the present invention;
Figures 3A and 3B are cross-sectional side views of a portion of the medical device assembly apparatus of Figure 1B along A-A' in the direction of the arrows, representing exemplary embodiments of assembly apparatus recesses.
Figures 4A and 4B are perspective and exploded perspective views, respectively, of an integrated medical device assembly apparatus according to another exemplary embodiment of the present invention;
Figure 5 is a flow chart illustrating a sequence of steps in a process for manufacturing an integrated medical device using the assembly apparatuses according to exemplary embodiments of the present invention;
Figures 6A-6H are schematic, perspective views depicting stages of a process for manufacturing medical devices according to present invention; and Figures 7A-7I are schematic perspective views depicting stages of a process for manufacturing medical devices according to the present invention.
DETAILED DESCRIPTION OF TAE INVENTION
Figure 1 is an exploded perspective view of a medical device assembly apparatus 100 according to an exemplary embodiment of the present invention.
' CA 02510876 2005-06-27 Assembly apparatus 100 includes a body 102, a detachable clamping bar 103 with a plurality of locating pins 104, and a detachable test strip pusher plate 106 with a plurality of spring-loaded protrusions 107. Assembly apparatus 100 is generally rectangular in shape and can be formed of metal or any material that can withstand a temperature ranging from about 95°C to 150°C.
Figures 2A and 2B are perspective and side views, respectively, of an exemplary integrated medical device 200 that can be manufactured using assembly apparatus 100 according to one aspect of the present invention. Integrated medical device 200 includes a test strip 204 and a dermal tissue penetration member 202. Test strip 204 has a reaction area 205 and electrical contacts 206 that terminate on a proximal end 210 of integrated medical device 200. Electrical contacts 206 are made of any suitable conductive material, such as gold, silver, platinum or carbon.
Dermal tissue penetration member 202 includes a lancet 220 adapted to pierce a user's skin and draw blood into reaction area 205. Dermal tissue penetration member 202 is adhered to test strip 204 by an adhesive layer 214. This adhesive layer 214 can be heat seal or pressure sensitive adhesive. Lancet 220 includes a lancet base 222 that terminates at the distal end 212 of the assembled test strip. Further descriptions of integrated medical devices that can be manufactured using assembly apparatus according to the present invention are in the aforementioned International Application No. PCT/GBO1/05634 and U.S. Patent Application No. 10/143,399. In addition, dermal tissue penetration member 202 can be fabricated, for example, by a progressive die-stamping technique, as disclosed in the aforementioned International Application No. PCT/GBO1/05634 and U.S. Patent Application No. 10/143,399.
Referring again to Figure 1, body 102 of assembly apparatus 100 includes a first side 108, a second side 110, a first end 112, a second end 114, an upper surface 116 and a lower surface 118. At first side 108 is a plurality of protrusion guides 119 which may be, for example hollow, tubular-shaped for the plurality of protrusions 107 to move through. The function of protrusions 107 is to move through protrusion guides 119 thereby pushing strips positioned in recess into alignment with dermal tissue penetration members 202 during the manufacturing F , ~ CA 02510876 2005-06-27 process, as will be described in more detail below (see Figures 5 and 6E). The cross section of protrusion guides 119 are shaped to accommodate the cross-sectional shape of protrusions 107.
Adjacent to protrusion guides 119 is a plurality of recesses 120 and groove 122 which may be, for example elongate in shape on upper surface 116 running from first end 112 to second end 114 (i.e., in the X direction of Figure 1) substantially parallel to first side 108. Adjacent to groove 122 are a plurality of locating pin receiving holes 126. The function of locating pin holes 126 is to align and secure clamping bar 103 through locating pins 104 to body upper surface 116, as will be described in more detail below (see Figures 5, 6C and 6D).
Recesses 120 each contain at least one recess wall 129 approximately perpendicular to groove 122 (i.e., in the Y direction, see Figure 1). Recess 120 is configured (e.g., sized, shaped andlor orientated) to receive and to removably retain a test strip 204 (illustrated in Figures 2A and 2B as part of integrated medical device 200) at least partially therein. The number of recesses 120 can range from 10 to 100 and more usually ranges from 20 to 50. The width of recess 120 (i.e., in the X
direction) is marginally larger (e.g., about 1-3%) than the width of test strip 204 such that test strip 204 fits snugly therein. This snug fit beneficially minimizes side-to-side movement of the strip during the integrated medical device assembly process (see Figure 5) such that alignment between test strip 204 and dermal tissue penetration member 202 in the X direction is maintained.
Recesses 120 can be formed by processes known to those skilled in the art including, but not limited to, spark erosion and electrical discharge machining (EDM). Types of EDM include, for example, wire, sinker and small hole EDM.
Cross-sectional side views of recess 120 are shown in Figures 3A and 3B.
Recess 120 includes at least one rounded inner corner 130 bounded by recess wall 129 and a recess base surface 131. An exemplary embodiment of recess 120 is shown in cross-section in Figure 3A. In this embodiment, test strip 204 within recess 120 contacts a region on corner 130 but does not contact recess base surface 131. In other words, . CA 02510876 2005-06-27 a test strip 204 is held remote from recess base surface 131 by corner 130 which may be, for example a rounded inner corner. Figure 3B illustrates another exemplary embodiment of recess 120 in which corners 130 are wire eroded to form a depression of approximate semi-circular cross section bounded by recess wall 129 and recess base surface 131 to allow test strip 204 to lie flat within recess 120. This beneficially allows close contact of test strip 204 with recess base surface 131, ensuring complete and even adhesion between test strip 204 and dermal tissue penetration member during the heat seal step in process 500 (see Figures 5, 6F and 6G).
Figures 4A and 4B are perspective and exploded perspective views, respectively, of a medical device assembly apparatus 400 according to another exemplary embodiment of the present invention. Assembly apparatus 400 includes a body 402, a detachable clamping bar 403 with a central locating pin 404, two outer locating pins 405 and a detachable spring-loaded test strip pusher plate 406.
Assembly apparatus 400 is generally rectangular in shape and can be formed of metal or any material that can withstand a temperature ranging from about 95°C to 150°C.
Assembly apparatus body 402 includes a first side 408, a second side 410, a first end 412, a second end 414, an upper surface 416 and a lower surface 418.
Second side 410 can include a stepped shape for securing assembly apparatus 400 in a heat-sealing apparatus prior to the integrated medical device assembly process.
Adjacent to first side 408 is an elongate recess-containing member 420 and groove 422 on upper surface 416 running from first end 412 to second end 414 (i.e., in the X
direction, see Figures 4A and 4B) substantially parallel to recess-containing member 420. Adjacent to groove 422 are outer locating pin slots 424 near to each of first and second ends 412 and 414. Also adjacent to groove 422 in substantially the center of body 402 is a central locating pin receiving hole 426. The function of outer locating pin slots 424 and central locating pin receiving hole 426 is to align and secure clamping bar 403 through central locating pin 404 and outer locating pin 405 to body upper surface 416, as will be described in more detail below (see Figures 5, 7E and 7F).
Figures 2A and 2B are perspective and side views, respectively, of an exemplary integrated medical device 200 that can be manufactured using assembly apparatus 100 according to one aspect of the present invention. Integrated medical device 200 includes a test strip 204 and a dermal tissue penetration member 202. Test strip 204 has a reaction area 205 and electrical contacts 206 that terminate on a proximal end 210 of integrated medical device 200. Electrical contacts 206 are made of any suitable conductive material, such as gold, silver, platinum or carbon.
Dermal tissue penetration member 202 includes a lancet 220 adapted to pierce a user's skin and draw blood into reaction area 205. Dermal tissue penetration member 202 is adhered to test strip 204 by an adhesive layer 214. This adhesive layer 214 can be heat seal or pressure sensitive adhesive. Lancet 220 includes a lancet base 222 that terminates at the distal end 212 of the assembled test strip. Further descriptions of integrated medical devices that can be manufactured using assembly apparatus according to the present invention are in the aforementioned International Application No. PCT/GBO1/05634 and U.S. Patent Application No. 10/143,399. In addition, dermal tissue penetration member 202 can be fabricated, for example, by a progressive die-stamping technique, as disclosed in the aforementioned International Application No. PCT/GBO1/05634 and U.S. Patent Application No. 10/143,399.
Referring again to Figure 1, body 102 of assembly apparatus 100 includes a first side 108, a second side 110, a first end 112, a second end 114, an upper surface 116 and a lower surface 118. At first side 108 is a plurality of protrusion guides 119 which may be, for example hollow, tubular-shaped for the plurality of protrusions 107 to move through. The function of protrusions 107 is to move through protrusion guides 119 thereby pushing strips positioned in recess into alignment with dermal tissue penetration members 202 during the manufacturing F , ~ CA 02510876 2005-06-27 process, as will be described in more detail below (see Figures 5 and 6E). The cross section of protrusion guides 119 are shaped to accommodate the cross-sectional shape of protrusions 107.
Adjacent to protrusion guides 119 is a plurality of recesses 120 and groove 122 which may be, for example elongate in shape on upper surface 116 running from first end 112 to second end 114 (i.e., in the X direction of Figure 1) substantially parallel to first side 108. Adjacent to groove 122 are a plurality of locating pin receiving holes 126. The function of locating pin holes 126 is to align and secure clamping bar 103 through locating pins 104 to body upper surface 116, as will be described in more detail below (see Figures 5, 6C and 6D).
Recesses 120 each contain at least one recess wall 129 approximately perpendicular to groove 122 (i.e., in the Y direction, see Figure 1). Recess 120 is configured (e.g., sized, shaped andlor orientated) to receive and to removably retain a test strip 204 (illustrated in Figures 2A and 2B as part of integrated medical device 200) at least partially therein. The number of recesses 120 can range from 10 to 100 and more usually ranges from 20 to 50. The width of recess 120 (i.e., in the X
direction) is marginally larger (e.g., about 1-3%) than the width of test strip 204 such that test strip 204 fits snugly therein. This snug fit beneficially minimizes side-to-side movement of the strip during the integrated medical device assembly process (see Figure 5) such that alignment between test strip 204 and dermal tissue penetration member 202 in the X direction is maintained.
Recesses 120 can be formed by processes known to those skilled in the art including, but not limited to, spark erosion and electrical discharge machining (EDM). Types of EDM include, for example, wire, sinker and small hole EDM.
Cross-sectional side views of recess 120 are shown in Figures 3A and 3B.
Recess 120 includes at least one rounded inner corner 130 bounded by recess wall 129 and a recess base surface 131. An exemplary embodiment of recess 120 is shown in cross-section in Figure 3A. In this embodiment, test strip 204 within recess 120 contacts a region on corner 130 but does not contact recess base surface 131. In other words, . CA 02510876 2005-06-27 a test strip 204 is held remote from recess base surface 131 by corner 130 which may be, for example a rounded inner corner. Figure 3B illustrates another exemplary embodiment of recess 120 in which corners 130 are wire eroded to form a depression of approximate semi-circular cross section bounded by recess wall 129 and recess base surface 131 to allow test strip 204 to lie flat within recess 120. This beneficially allows close contact of test strip 204 with recess base surface 131, ensuring complete and even adhesion between test strip 204 and dermal tissue penetration member during the heat seal step in process 500 (see Figures 5, 6F and 6G).
Figures 4A and 4B are perspective and exploded perspective views, respectively, of a medical device assembly apparatus 400 according to another exemplary embodiment of the present invention. Assembly apparatus 400 includes a body 402, a detachable clamping bar 403 with a central locating pin 404, two outer locating pins 405 and a detachable spring-loaded test strip pusher plate 406.
Assembly apparatus 400 is generally rectangular in shape and can be formed of metal or any material that can withstand a temperature ranging from about 95°C to 150°C.
Assembly apparatus body 402 includes a first side 408, a second side 410, a first end 412, a second end 414, an upper surface 416 and a lower surface 418.
Second side 410 can include a stepped shape for securing assembly apparatus 400 in a heat-sealing apparatus prior to the integrated medical device assembly process.
Adjacent to first side 408 is an elongate recess-containing member 420 and groove 422 on upper surface 416 running from first end 412 to second end 414 (i.e., in the X
direction, see Figures 4A and 4B) substantially parallel to recess-containing member 420. Adjacent to groove 422 are outer locating pin slots 424 near to each of first and second ends 412 and 414. Also adjacent to groove 422 in substantially the center of body 402 is a central locating pin receiving hole 426. The function of outer locating pin slots 424 and central locating pin receiving hole 426 is to align and secure clamping bar 403 through central locating pin 404 and outer locating pin 405 to body upper surface 416, as will be described in more detail below (see Figures 5, 7E and 7F).
,. , Recess-containing member 420 includes a plurality of recesses 428 each containing at least one recess wall 429 approximately perpendicular to groove 422 (i.e., in the Y direction, see Figures 4A and 4B). Recess 428 is configured (e.g., sized, shaped and/or orientated) to receive and to removably retain a test strip 204 (illustrated in Figures 2A and 2B as part of integrated medical device 200) at least partially therein. The number of recesses 428 can range from 10 to 100 and more and usually ranges from 20 to 50. The width of recess 428 (i.e., in the X
direction) is marginally larger (e.g., about 1-3%) than the width of test strip 204 such that test strip 204 fits snugly therein. This snug fit beneficially minimizes side-to-side movement of the strip during the integrated medical device assembly process (see Figure 5) such that alignment between test strip 204 and dermal tissue penetration member 202 in the X direction is maintained.
Recess-containing member 420 is securely attached to body 402 by means or processes known to those skilled in the art including, for example, bolting, dowelling and welding. Recess-containing member 420 is fabricated separately from body 402 so that recesses 428 can be formed by processes known to those skilled in the art including, but not limited to, spark erosion and electrical discharge machining (EDM). Types of EDM include, for example, wire, sinker and small hole EDM. The exemplary embodiments of recess 428 shown in Figures 3A and 3B can also be used in assembly apparatus 400.
Referring again to Figures 4A and 4B, pusher plate 406 includes a plate proximal side 432 facing recess-containing member 420, a plate distal side 434, a first end 436 and a second end 438. Plate proximal side 432 includes a resiliently deformable band 440 along the entire length of plate 406 from first end 436 to second end 438 and extending to approximately half the height and width of pusher plate 406.
Deformable band 440 contacts test strips 204 as pusher plate 406 is urged against recess-containing member 420, as will be described below (see Figures 5 and 7G).
Deformable band 440 can be formed of any resiliently deformable material known to those skilled in the art including, but not limited to, Styrofoam materials, elastomeric materials, silicone materials, latex materials, polymeric materials, polyurethane materials and any combination thereof. Deformable band is detachably adhered to pusher plate 406 with semi-permanent adhesive to allow for removal when deformable band 440 is no longer functional, is soiled or is damaged.
Any suitable adhesive known to those skilled in the art can be employed for this purpose including, but not limited to, pressure sensitive adhesives, cold-seal adhesives, heat-seal adhesives and releasable adhesives available from, for example, 3M, Basic Adhesives and Avery Dennison.
Referring to Figure 4B, pusher plate 406 further includes at least one outer screw 442 with a spring 444 in surrounding relation to outer screw threads 445 and at least one inner screw 446. A non-threaded outer screw plate hole 450 allows movement of pusher plate 406 relative to outer screw 442. Outer screw 442 is anchored in recess-containing member 420 through an outer screw threaded body hole 1 S 452 that is aligned with non-threaded screw plate hole 450. Inner screws 446 can move through the width of pusher plate 406 by threaded inner through screw hole 448. Outer screws) 442 and inner screws) 446 are positioned inward from plate first end 436 and second end 438 approximately one quarter and one third of the length, respectively, of pusher plate 406 running in the X direction. Outer screw 442 and inner screw 446 are also positioned in pusher plate 406 below deformable band such that movement of pusher plate 406 with respect to recess-containing member 420 on outer screw 442 and inner screw 446 is not impeded by deformable band 440.
Outer screw threaded body holes 452 are also included in recess-containing member 420 for receiving outer screws 442. Outer screws 442 are screwed into recess-containing member 420 through outer screw threaded body holes 452 to a depth sufficient to allow movement of plate pusher 406 away from recess-containing member 420 and to allow compression of springs 444. Inner screws 446 can touch but do not penetrate recess-containing member 420.
Figure 5 is a flow chart illustrating a sequence of steps in a process 500 for manufacturing a plurality of integrated medical devices according to an exemplary embodiment of the present invention. Process 500 is described below utilizing , , Figures 6A-6I and 7A-7I (schematic, perspective views depicting various stages of process 500). Process 500 will first be described utilizing assembly apparatus shown in Figures 6A-6I and then will be described utilizing assembly apparatus shown in Figures 7A-7I.
Process 500 includes first providing an assembly apparatus 100, as set forth in step 510 of Figure 5 (see Figure 1). The provided assembly apparatus includes a body 102, a clamping bar 103 with a plurality of locating pins 104, and a pusher plate 106 with a plurality of protrusions 107 which may be, for example, spring-loaded. Body 102 further includes a first side with a plurality of hollow protrusion guides 119 for the protrusions 107 to move therethrough. Adjacent to protrusion guides 119 is a plurality of recesses 120 configured to receive and to removably retain test strips 204 at least partially therein.
Next, as set forth in step 520, a previously fabricated test strip 204 with an exposed upper heat seal adhesive layer is placed in each recess 120 in assembly apparatus 100 (see Figure 6A). Test strips 204 used in this process can be manufactured, for example, by web processes as disclosed in U.S. Patent Application Nos. 10/143,999 and 10/142,409 or by screen printing processes as disclosed in International Application No. PCT/GB03/04656 (DDI-5019 PCT; filed on October 30, 2003).
As set forth in step 530, a set of 10 to 50 dermal tissue penetration members 202 attached to a common bandolier 154 through tabs 156 is next placed on top of test strips 204 in assembly apparatus 100 such that at least one bandolier hole 158 is aligned with at least one locating pin receiving hole 126 (see Figures 6B-6C).
Subsequently, clamping bar 103 is attached to body upper surface 116 by placing locating pins 104 through bandolier holes 158 and locating pin receiving holes 126, thereby securing bandolier 154 (see Figures 6D), as set forth in step 540.
Locating pins 104 beneficially securely hold bandolier 154 in place to ensure that ~._* . .: .
there is minimal movement of dermal tissue penetration members 202 in the X, Y
and Z directions during step 560 (see below).
As set forth in step 550, pusher plate 106 is urged toward body 102, causing test strips 204 to be pushed toward body 102 in the Y direction by protrusions 107 (not shown). Protrusions 107 continue to push test strips 204 until the reaction areas on test strips 204 are aligned with a lancet base 222 (see Figure 6E;
strips and lancet base not shown). Movement of protrusions 107 in the Y direction is optionally guided by protrusion guides 119. Protrusions 107 are spring loaded to accommodate variations in test strip length while ensuring that the strips are fully pushed against lancet base 222.
Next, assembly apparatus 100 is placed in a heat sealing apparatus and dermal tissue penetration members 202 are adhered to test strips 204 by a heat sealer 160, as set forth in step 560 (see Figures 6F-6G). Any heat sealer known to those skilled in the art can be used in this step. Heat sealer 160 seals 2 to 20 medical devices at a time and more usually seals 5 to 10 at one time. Typical temperature, pressure and dwell times (i.e., time that the heat sealer contacts the dermal tissue penetration member) for heat sealer 160 range from 95-150°C, 15-40 N
per lancet, and 1-5 seconds, respectively. The assembled integrated medical devices 200 attached to bandolier 154 (see Figure 6I~ are then removed from assembly apparatus 100 for further processing, i.e. for singulation by cutting through tabs 156 that connect dermal tissue penetration member 202 to the bandolier 154.
When assembly apparatus 400 is used in process 500, process 500 includes first providing an assembly apparatus 400, as set forth in step 510 of Figure 5 (see Figure 7A). The provided assembly apparatus includes a body 402, a clamping bar 403 with a central locating pin 404 and outer locating pins 405 for attaching clamping bar 403 to body 402, and a pusher plate 406 which may be, for example spring-loaded. Body 402 includes a recess-containing member 420 containing a plurality of recesses 428 for receiving test strips therein. The pusher plate includes an optional resiliently deformable band 440 for contacting the test strips ..... _~
during the manufacturing process. Pusher plate 406 further includes at least one outer screw 442 with a spring 444 in sunrounding relation to outer screw threads 445 and at least one inner screw 446. Pusher plate 406 can move relative to outer screw 442.
Outer screw 442 is anchored in recess-containing member 420 and remains stationary during process 500. Inner screw 446 moves through pusher plate though a threaded inner screw hole 448 and touches but does not penetrate recess-containing member 420. In step 510, pusher plate 406 has been moved away from recess-containing member 420 by turning inner screws 446 clockwise. This allows placement of test strips 204 into recesses 428 (see step 520). Turning inner screws clockwise causes inner screws 446 to push against recess-containing member 420, resulting in movement of pusher plate 406 away from recess-containing member 420 and compression of springs 444. Pusher plate 406 is now spring-loaded in preparation for assembling integrated medical devices.
1 S Next, as set forth in step 520, a previously fabricated test strip 204 with an exposed upper heat seal adhesive layer is placed in each recess 428 in assembly apparatus 400 (see Figure 7B).
As set forth in step 530, a set of 10 to 50 dermal tissue penetration members 202 attached to common bandolier 454 through tabs 456 is next placed on top of test strips 204 in assembly apparatus 400 such that at least one bandolier hole 458 is aligned with central locating pin receiving hole 426 and at least one outer locating pin slot 424 (see Figures 7C-7D).
Subsequently, clamping bar 403 is attached to body upper surface 416 by placing central locating and outer locating pins 404 and 405 through bandolier holes 458 and outer locating pin slots 424 and central locating pin receiving hole 426, thereby securing bandolier 454 (see Figures 7E-7F), as set forth in step 540.
Central locating pin 404 fits securely into body 402 of assembly apparatus 400, whereas at least one outer locating pin 405 fits into outer locating pin slots 424 in body 402, allowing outer locating pins 405 to move as needed during the manufacturing process.
Central locating pin 404 beneficially securely holds bandolier 454 in place to ensure . p ,. "~ ... .
, CA 02510876 2005-06-27 that there is minimal movement of dermal tissue penetration members 202 in the X
direction during step 560. The combination of a fixed central locating pin 404 and moveable outer locating pins 405 beneficially improves the alignment tolerance for the dermal tissue penetration members relative to the test strips by allowing the S penetration members to move on either side of the central locating pin rather than moving the entire length of the bandolier. This configuration therefore effectively halves the alignment tolerance in the X direction.
As set forth in step 550, test strips 204 are pushed toward body 402 in the Y direction by pusher plate 406 such that the reaction area on test strips 204 are aligned with lancet base 222 (see Figure 7G; strips and lancet base not shown).
Movement of pusher plate 406 in the Y direction is achieved by turning inner screws 446 counter-clockwise to release springs 444. As pusher plate 406 moves in the Y
direction, deformable band 440 contacts test strips 204, subsequently pushing strips into position. Deformable band 440 beneficially accommodates variations in test strip length while ensuring that the strips are fully pushed against the base of lancet 220.
Next, assembly apparatus 400 is placed in a heat sealing apparatus and dermal tissue penetration members 202 are adhered to test strips 204 by a heat sealer 160, as set forth in step 560 (see Figures 7H-7I). Any heat sealer known to those skilled in the art can be used in this step. Heat sealer 160 seals 2 to 20 medical devices at a time and more usually seals 5 to 10 at one time. Typical temperature, pressure and dwell times (i.e., time that the heat sealer contacts the dermal tissue penetration member) for heat sealer 160 range from 95-150°C, 15-40 N
per lancet, and 1-5 seconds, respectively. The assembled integrated medical devices 200 attached to bandolier 154 (see Figure 6H) are then removed from assembly apparatus 400 for further processing, i.e. for singulation by cutting through tabs 156 that connect dermal tissue penetration member 202 to the bandolier 154.
Each of the steps of process 500 can be performed, for example, either manually by a user or with the aid of a mechanical and/or electrical device.
' CA 02510876 2005-06-27 Once apprised of the present disclosure, one skilled in the art will recognize that a variety of medical devices can be beneficially manufactured according to the present invention. Such medical devices include, but are not limited to, integrated medical devices that include a combination of a test strip and a lancet, examples of which are described in the aforementioned International Application No.
PCT/GBO1/05634 (published as WO 02/49507 on June 27, 2002) and U.S. Patent Application No. 10/143,399. One skilled in the art will also recognize that such test strips may have, but are not limited to, an electrochemical or photometric configuration. For illustrative purposes only, medical devices in various figures of the present disclosure were depicted as having an electrochemical configuration.
Moreover, those skilled in the art will appreciate that medical devices according to embodiments of the present invention can be adapted for the measurement of, for example, glucose, ketones, glycated albumin, coagulation parameters and cholesterol of a sample.
In addition, one skilled in the art will also recognize that medical devices according to the present invention may be contained within a combined sample collection and metering system designed for in-situ testing. Examples of such systems designed for in-situ testing are disclosed in International Patent Application No. PCT/USO1/07169 (published as WO 01/64105 A1 on September 7, 2001) and International Patent Application No. PCT/GB02/03772 (published as WO 03/015627 A1 on February 27, 2003).
It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.
direction) is marginally larger (e.g., about 1-3%) than the width of test strip 204 such that test strip 204 fits snugly therein. This snug fit beneficially minimizes side-to-side movement of the strip during the integrated medical device assembly process (see Figure 5) such that alignment between test strip 204 and dermal tissue penetration member 202 in the X direction is maintained.
Recess-containing member 420 is securely attached to body 402 by means or processes known to those skilled in the art including, for example, bolting, dowelling and welding. Recess-containing member 420 is fabricated separately from body 402 so that recesses 428 can be formed by processes known to those skilled in the art including, but not limited to, spark erosion and electrical discharge machining (EDM). Types of EDM include, for example, wire, sinker and small hole EDM. The exemplary embodiments of recess 428 shown in Figures 3A and 3B can also be used in assembly apparatus 400.
Referring again to Figures 4A and 4B, pusher plate 406 includes a plate proximal side 432 facing recess-containing member 420, a plate distal side 434, a first end 436 and a second end 438. Plate proximal side 432 includes a resiliently deformable band 440 along the entire length of plate 406 from first end 436 to second end 438 and extending to approximately half the height and width of pusher plate 406.
Deformable band 440 contacts test strips 204 as pusher plate 406 is urged against recess-containing member 420, as will be described below (see Figures 5 and 7G).
Deformable band 440 can be formed of any resiliently deformable material known to those skilled in the art including, but not limited to, Styrofoam materials, elastomeric materials, silicone materials, latex materials, polymeric materials, polyurethane materials and any combination thereof. Deformable band is detachably adhered to pusher plate 406 with semi-permanent adhesive to allow for removal when deformable band 440 is no longer functional, is soiled or is damaged.
Any suitable adhesive known to those skilled in the art can be employed for this purpose including, but not limited to, pressure sensitive adhesives, cold-seal adhesives, heat-seal adhesives and releasable adhesives available from, for example, 3M, Basic Adhesives and Avery Dennison.
Referring to Figure 4B, pusher plate 406 further includes at least one outer screw 442 with a spring 444 in surrounding relation to outer screw threads 445 and at least one inner screw 446. A non-threaded outer screw plate hole 450 allows movement of pusher plate 406 relative to outer screw 442. Outer screw 442 is anchored in recess-containing member 420 through an outer screw threaded body hole 1 S 452 that is aligned with non-threaded screw plate hole 450. Inner screws 446 can move through the width of pusher plate 406 by threaded inner through screw hole 448. Outer screws) 442 and inner screws) 446 are positioned inward from plate first end 436 and second end 438 approximately one quarter and one third of the length, respectively, of pusher plate 406 running in the X direction. Outer screw 442 and inner screw 446 are also positioned in pusher plate 406 below deformable band such that movement of pusher plate 406 with respect to recess-containing member 420 on outer screw 442 and inner screw 446 is not impeded by deformable band 440.
Outer screw threaded body holes 452 are also included in recess-containing member 420 for receiving outer screws 442. Outer screws 442 are screwed into recess-containing member 420 through outer screw threaded body holes 452 to a depth sufficient to allow movement of plate pusher 406 away from recess-containing member 420 and to allow compression of springs 444. Inner screws 446 can touch but do not penetrate recess-containing member 420.
Figure 5 is a flow chart illustrating a sequence of steps in a process 500 for manufacturing a plurality of integrated medical devices according to an exemplary embodiment of the present invention. Process 500 is described below utilizing , , Figures 6A-6I and 7A-7I (schematic, perspective views depicting various stages of process 500). Process 500 will first be described utilizing assembly apparatus shown in Figures 6A-6I and then will be described utilizing assembly apparatus shown in Figures 7A-7I.
Process 500 includes first providing an assembly apparatus 100, as set forth in step 510 of Figure 5 (see Figure 1). The provided assembly apparatus includes a body 102, a clamping bar 103 with a plurality of locating pins 104, and a pusher plate 106 with a plurality of protrusions 107 which may be, for example, spring-loaded. Body 102 further includes a first side with a plurality of hollow protrusion guides 119 for the protrusions 107 to move therethrough. Adjacent to protrusion guides 119 is a plurality of recesses 120 configured to receive and to removably retain test strips 204 at least partially therein.
Next, as set forth in step 520, a previously fabricated test strip 204 with an exposed upper heat seal adhesive layer is placed in each recess 120 in assembly apparatus 100 (see Figure 6A). Test strips 204 used in this process can be manufactured, for example, by web processes as disclosed in U.S. Patent Application Nos. 10/143,999 and 10/142,409 or by screen printing processes as disclosed in International Application No. PCT/GB03/04656 (DDI-5019 PCT; filed on October 30, 2003).
As set forth in step 530, a set of 10 to 50 dermal tissue penetration members 202 attached to a common bandolier 154 through tabs 156 is next placed on top of test strips 204 in assembly apparatus 100 such that at least one bandolier hole 158 is aligned with at least one locating pin receiving hole 126 (see Figures 6B-6C).
Subsequently, clamping bar 103 is attached to body upper surface 116 by placing locating pins 104 through bandolier holes 158 and locating pin receiving holes 126, thereby securing bandolier 154 (see Figures 6D), as set forth in step 540.
Locating pins 104 beneficially securely hold bandolier 154 in place to ensure that ~._* . .: .
there is minimal movement of dermal tissue penetration members 202 in the X, Y
and Z directions during step 560 (see below).
As set forth in step 550, pusher plate 106 is urged toward body 102, causing test strips 204 to be pushed toward body 102 in the Y direction by protrusions 107 (not shown). Protrusions 107 continue to push test strips 204 until the reaction areas on test strips 204 are aligned with a lancet base 222 (see Figure 6E;
strips and lancet base not shown). Movement of protrusions 107 in the Y direction is optionally guided by protrusion guides 119. Protrusions 107 are spring loaded to accommodate variations in test strip length while ensuring that the strips are fully pushed against lancet base 222.
Next, assembly apparatus 100 is placed in a heat sealing apparatus and dermal tissue penetration members 202 are adhered to test strips 204 by a heat sealer 160, as set forth in step 560 (see Figures 6F-6G). Any heat sealer known to those skilled in the art can be used in this step. Heat sealer 160 seals 2 to 20 medical devices at a time and more usually seals 5 to 10 at one time. Typical temperature, pressure and dwell times (i.e., time that the heat sealer contacts the dermal tissue penetration member) for heat sealer 160 range from 95-150°C, 15-40 N
per lancet, and 1-5 seconds, respectively. The assembled integrated medical devices 200 attached to bandolier 154 (see Figure 6I~ are then removed from assembly apparatus 100 for further processing, i.e. for singulation by cutting through tabs 156 that connect dermal tissue penetration member 202 to the bandolier 154.
When assembly apparatus 400 is used in process 500, process 500 includes first providing an assembly apparatus 400, as set forth in step 510 of Figure 5 (see Figure 7A). The provided assembly apparatus includes a body 402, a clamping bar 403 with a central locating pin 404 and outer locating pins 405 for attaching clamping bar 403 to body 402, and a pusher plate 406 which may be, for example spring-loaded. Body 402 includes a recess-containing member 420 containing a plurality of recesses 428 for receiving test strips therein. The pusher plate includes an optional resiliently deformable band 440 for contacting the test strips ..... _~
during the manufacturing process. Pusher plate 406 further includes at least one outer screw 442 with a spring 444 in sunrounding relation to outer screw threads 445 and at least one inner screw 446. Pusher plate 406 can move relative to outer screw 442.
Outer screw 442 is anchored in recess-containing member 420 and remains stationary during process 500. Inner screw 446 moves through pusher plate though a threaded inner screw hole 448 and touches but does not penetrate recess-containing member 420. In step 510, pusher plate 406 has been moved away from recess-containing member 420 by turning inner screws 446 clockwise. This allows placement of test strips 204 into recesses 428 (see step 520). Turning inner screws clockwise causes inner screws 446 to push against recess-containing member 420, resulting in movement of pusher plate 406 away from recess-containing member 420 and compression of springs 444. Pusher plate 406 is now spring-loaded in preparation for assembling integrated medical devices.
1 S Next, as set forth in step 520, a previously fabricated test strip 204 with an exposed upper heat seal adhesive layer is placed in each recess 428 in assembly apparatus 400 (see Figure 7B).
As set forth in step 530, a set of 10 to 50 dermal tissue penetration members 202 attached to common bandolier 454 through tabs 456 is next placed on top of test strips 204 in assembly apparatus 400 such that at least one bandolier hole 458 is aligned with central locating pin receiving hole 426 and at least one outer locating pin slot 424 (see Figures 7C-7D).
Subsequently, clamping bar 403 is attached to body upper surface 416 by placing central locating and outer locating pins 404 and 405 through bandolier holes 458 and outer locating pin slots 424 and central locating pin receiving hole 426, thereby securing bandolier 454 (see Figures 7E-7F), as set forth in step 540.
Central locating pin 404 fits securely into body 402 of assembly apparatus 400, whereas at least one outer locating pin 405 fits into outer locating pin slots 424 in body 402, allowing outer locating pins 405 to move as needed during the manufacturing process.
Central locating pin 404 beneficially securely holds bandolier 454 in place to ensure . p ,. "~ ... .
, CA 02510876 2005-06-27 that there is minimal movement of dermal tissue penetration members 202 in the X
direction during step 560. The combination of a fixed central locating pin 404 and moveable outer locating pins 405 beneficially improves the alignment tolerance for the dermal tissue penetration members relative to the test strips by allowing the S penetration members to move on either side of the central locating pin rather than moving the entire length of the bandolier. This configuration therefore effectively halves the alignment tolerance in the X direction.
As set forth in step 550, test strips 204 are pushed toward body 402 in the Y direction by pusher plate 406 such that the reaction area on test strips 204 are aligned with lancet base 222 (see Figure 7G; strips and lancet base not shown).
Movement of pusher plate 406 in the Y direction is achieved by turning inner screws 446 counter-clockwise to release springs 444. As pusher plate 406 moves in the Y
direction, deformable band 440 contacts test strips 204, subsequently pushing strips into position. Deformable band 440 beneficially accommodates variations in test strip length while ensuring that the strips are fully pushed against the base of lancet 220.
Next, assembly apparatus 400 is placed in a heat sealing apparatus and dermal tissue penetration members 202 are adhered to test strips 204 by a heat sealer 160, as set forth in step 560 (see Figures 7H-7I). Any heat sealer known to those skilled in the art can be used in this step. Heat sealer 160 seals 2 to 20 medical devices at a time and more usually seals 5 to 10 at one time. Typical temperature, pressure and dwell times (i.e., time that the heat sealer contacts the dermal tissue penetration member) for heat sealer 160 range from 95-150°C, 15-40 N
per lancet, and 1-5 seconds, respectively. The assembled integrated medical devices 200 attached to bandolier 154 (see Figure 6H) are then removed from assembly apparatus 400 for further processing, i.e. for singulation by cutting through tabs 156 that connect dermal tissue penetration member 202 to the bandolier 154.
Each of the steps of process 500 can be performed, for example, either manually by a user or with the aid of a mechanical and/or electrical device.
' CA 02510876 2005-06-27 Once apprised of the present disclosure, one skilled in the art will recognize that a variety of medical devices can be beneficially manufactured according to the present invention. Such medical devices include, but are not limited to, integrated medical devices that include a combination of a test strip and a lancet, examples of which are described in the aforementioned International Application No.
PCT/GBO1/05634 (published as WO 02/49507 on June 27, 2002) and U.S. Patent Application No. 10/143,399. One skilled in the art will also recognize that such test strips may have, but are not limited to, an electrochemical or photometric configuration. For illustrative purposes only, medical devices in various figures of the present disclosure were depicted as having an electrochemical configuration.
Moreover, those skilled in the art will appreciate that medical devices according to embodiments of the present invention can be adapted for the measurement of, for example, glucose, ketones, glycated albumin, coagulation parameters and cholesterol of a sample.
In addition, one skilled in the art will also recognize that medical devices according to the present invention may be contained within a combined sample collection and metering system designed for in-situ testing. Examples of such systems designed for in-situ testing are disclosed in International Patent Application No. PCT/USO1/07169 (published as WO 01/64105 A1 on September 7, 2001) and International Patent Application No. PCT/GB02/03772 (published as WO 03/015627 A1 on February 27, 2003).
It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.
Claims (4)
1. A method of assembling integrated medical devices, the method comprising:
providing a medical device assembly apparatus including:
a body including:
a proximal end; and a distal end;
a detachable clamping bar; and a pusher plate, wherein said proximal end includes a plurality of recesses for receiving and removably retaining a plurality of test strips at least partially therein;
loading a test strip containing a top layer of heat-seal adhesive into each recess placing a plurality of tissue penetration members on top of said test strips;
securing said plurality of tissue penetration members with said clamping bar to minimize movement;
urging said test strips into alignment with said tissue penetration members using said pusher plate;
heating said tissue penetration members to a predetermined temperature to bond said strips to said tissue penetration members; and removing said medical devices from said assembly apparatus for further processing.
providing a medical device assembly apparatus including:
a body including:
a proximal end; and a distal end;
a detachable clamping bar; and a pusher plate, wherein said proximal end includes a plurality of recesses for receiving and removably retaining a plurality of test strips at least partially therein;
loading a test strip containing a top layer of heat-seal adhesive into each recess placing a plurality of tissue penetration members on top of said test strips;
securing said plurality of tissue penetration members with said clamping bar to minimize movement;
urging said test strips into alignment with said tissue penetration members using said pusher plate;
heating said tissue penetration members to a predetermined temperature to bond said strips to said tissue penetration members; and removing said medical devices from said assembly apparatus for further processing.
2. The method of Claim 1, wherein heat is applied evenly across said tissue penetration members to ensure complete adhesion between said strips and said dermal tissue penetration members.
3. The method of Claim 1, wherein said tissue penetration members are connected by a bandolier.
4. The method of Claim 1, where said predetermined temperature is between 95°C and 150°C.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/881,306 US20060000549A1 (en) | 2004-06-29 | 2004-06-29 | Method of manufacturing integrated biosensors |
US10/881,306 | 2004-06-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2510876A1 true CA2510876A1 (en) | 2005-12-29 |
Family
ID=34941774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002510876A Abandoned CA2510876A1 (en) | 2004-06-29 | 2005-06-27 | Method of manufacturing integrated biosensors |
Country Status (13)
Country | Link |
---|---|
US (1) | US20060000549A1 (en) |
EP (1) | EP1611849A1 (en) |
JP (1) | JP2006015142A (en) |
KR (1) | KR20060048600A (en) |
CN (1) | CN1715917A (en) |
AU (1) | AU2005202537A1 (en) |
CA (1) | CA2510876A1 (en) |
IL (1) | IL169105A0 (en) |
MX (1) | MXPA05007062A (en) |
NO (1) | NO20053169L (en) |
RU (1) | RU2005120102A (en) |
SG (1) | SG118422A1 (en) |
TW (1) | TW200600055A (en) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6036924A (en) * | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
DE10057832C1 (en) * | 2000-11-21 | 2002-02-21 | Hartmann Paul Ag | Blood analysis device has syringe mounted in casing, annular mounting carrying needles mounted behind test strip and being swiveled so that needle can be pushed through strip and aperture in casing to take blood sample |
US8337419B2 (en) * | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US7749174B2 (en) * | 2001-06-12 | 2010-07-06 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
ATE485766T1 (en) | 2001-06-12 | 2010-11-15 | Pelikan Technologies Inc | ELECTRICAL ACTUATING ELEMENT FOR A LANCET |
US7682318B2 (en) * | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
US20070100255A1 (en) * | 2002-04-19 | 2007-05-03 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
EP1404234B1 (en) * | 2001-06-12 | 2011-02-09 | Pelikan Technologies Inc. | Apparatus for improving success rate of blood yield from a fingerstick |
DE60234598D1 (en) | 2001-06-12 | 2010-01-14 | Pelikan Technologies Inc | SELF-OPTIMIZING LANZET DEVICE WITH ADAPTANT FOR TEMPORAL FLUCTUATIONS OF SKIN PROPERTIES |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7491178B2 (en) * | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7563232B2 (en) * | 2002-04-19 | 2009-07-21 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7141058B2 (en) * | 2002-04-19 | 2006-11-28 | Pelikan Technologies, Inc. | Method and apparatus for a body fluid sampling device using illumination |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7976476B2 (en) * | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7410468B2 (en) * | 2002-04-19 | 2008-08-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7371247B2 (en) * | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7524293B2 (en) * | 2002-04-19 | 2009-04-28 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7901362B2 (en) * | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7232451B2 (en) * | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7674232B2 (en) * | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7297122B2 (en) * | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7485128B2 (en) * | 2002-04-19 | 2009-02-03 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7481776B2 (en) * | 2002-04-19 | 2009-01-27 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
AU2003300154A1 (en) * | 2002-12-31 | 2004-07-29 | Pelikan Technologies Inc. | Method and apparatus for loading penetrating members |
DK1633235T3 (en) | 2003-06-06 | 2014-08-18 | Sanofi Aventis Deutschland | Apparatus for sampling body fluid and detecting analyte |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
WO2005006939A2 (en) * | 2003-06-11 | 2005-01-27 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US8282576B2 (en) * | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
EP1680014A4 (en) * | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | Method and apparatus for a variable user interface |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | Method and apparatus for a fluid sampling device |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
WO2007044599A2 (en) * | 2005-10-06 | 2007-04-19 | Hamilton Scott E | Pod connected data monitoring system |
EP1818014A1 (en) | 2006-02-09 | 2007-08-15 | F. Hoffmann-la Roche AG | Test element with elastically supported lancet |
WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
US8956308B2 (en) | 2008-09-29 | 2015-02-17 | Bayer Healthcare Llc | Integrated-testing system |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
CN103465020B (en) * | 2013-09-11 | 2016-01-06 | 昆山科森科技股份有限公司 | The accurate apparatus for assembling of medical assembly |
CN106239136B (en) * | 2013-09-11 | 2018-06-19 | 科森科技东台有限公司 | The efficient assembly system of high stability |
CN106271597B (en) * | 2013-09-11 | 2018-05-01 | 科森科技东台有限公司 | Assembling device for precision part |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6706159B2 (en) | 2000-03-02 | 2004-03-16 | Diabetes Diagnostics | Combined lancet and electrochemical analyte-testing apparatus |
GB0030929D0 (en) | 2000-12-19 | 2001-01-31 | Inverness Medical Ltd | Analyte measurement |
WO2003015627A2 (en) | 2001-08-16 | 2003-02-27 | Inverness Medical Limited | In-situ adapter for an analyte testing device |
DE10142232B4 (en) * | 2001-08-29 | 2021-04-29 | Roche Diabetes Care Gmbh | Process for the production of an analytical aid with a lancet and test element |
US7226461B2 (en) * | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US7060192B2 (en) | 2002-05-09 | 2006-06-13 | Lifescan, Inc. | Methods of fabricating physiological sample collection devices |
US20030211619A1 (en) * | 2002-05-09 | 2003-11-13 | Lorin Olson | Continuous strip of fluid sampling and testing devices and methods of making, packaging and using the same |
US20030143113A2 (en) * | 2002-05-09 | 2003-07-31 | Lifescan, Inc. | Physiological sample collection devices and methods of using the same |
US20030212344A1 (en) * | 2002-05-09 | 2003-11-13 | Vadim Yuzhakov | Physiological sample collection devices and methods of using the same |
US6589261B1 (en) * | 2002-08-19 | 2003-07-08 | Vitalcare Group, Inc. | Lancet needle anchor and method |
KR101106942B1 (en) | 2002-10-30 | 2012-01-19 | 인버니스 메디컬 리미티드 | Apparatus and method for controlling registration of print steps in a continuous process for the manufacture of electrochemical sensors |
-
2004
- 2004-06-29 US US10/881,306 patent/US20060000549A1/en not_active Abandoned
-
2005
- 2005-06-09 IL IL169105A patent/IL169105A0/en unknown
- 2005-06-10 AU AU2005202537A patent/AU2005202537A1/en not_active Abandoned
- 2005-06-27 CA CA002510876A patent/CA2510876A1/en not_active Abandoned
- 2005-06-28 JP JP2005188691A patent/JP2006015142A/en active Pending
- 2005-06-28 RU RU2005120102/14A patent/RU2005120102A/en not_active Application Discontinuation
- 2005-06-28 EP EP05254022A patent/EP1611849A1/en not_active Withdrawn
- 2005-06-28 KR KR1020050056176A patent/KR20060048600A/en not_active Application Discontinuation
- 2005-06-28 TW TW094121636A patent/TW200600055A/en unknown
- 2005-06-28 NO NO20053169A patent/NO20053169L/en not_active Application Discontinuation
- 2005-06-28 MX MXPA05007062A patent/MXPA05007062A/en not_active Application Discontinuation
- 2005-06-29 CN CNA2005100810758A patent/CN1715917A/en active Pending
- 2005-06-29 SG SG200504129A patent/SG118422A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1715917A (en) | 2006-01-04 |
NO20053169D0 (en) | 2005-06-28 |
EP1611849A1 (en) | 2006-01-04 |
MXPA05007062A (en) | 2006-01-11 |
NO20053169L (en) | 2005-12-30 |
TW200600055A (en) | 2006-01-01 |
RU2005120102A (en) | 2007-01-10 |
IL169105A0 (en) | 2007-07-04 |
US20060000549A1 (en) | 2006-01-05 |
KR20060048600A (en) | 2006-05-18 |
SG118422A1 (en) | 2006-01-27 |
AU2005202537A1 (en) | 2006-01-12 |
JP2006015142A (en) | 2006-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1611849A1 (en) | Method of manufacturing integrated biosensors | |
EP1611842A1 (en) | Apparatus for the manufacture of medical devices | |
US7051495B2 (en) | Method of packaging integrated biosensors | |
US7396334B2 (en) | Analytical device with lancet and test element | |
US7749174B2 (en) | Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge | |
EP3777658A1 (en) | Physiological signal monitoring device and sensor holder thereof | |
US8328735B2 (en) | Analytical system for detecting an analyte in a body fluid and disposable integrated puncturing and analyzing element | |
US20040098008A1 (en) | Precisely guided lancet | |
EP1612143A1 (en) | Apparatus for the packaging of medical devices including integrated lancets | |
US8172866B2 (en) | Medical aid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |